SWHR Provides Input on ICER Value Assessment Framework

Policy Engagement

Published 6/10/19

SWHR provided input to the Institute for Clinical and Economic Review (ICER) on the 2020 update to its value assessment framework. SWHR is committed to ensuring value frameworks are designed to incorporate the multitude of patient experiences, including women – who frequently act as patients, caregivers, and health care decision-makers for themselves and their families. Therefore, SWHR recommended that ICER account for diversity (including sex and gender diversity) within models, explore subpopulation value metrics, and ascertain whether clinical trial data used are representative of the relevant patient population.

In ensuring that patient experience is captured within the value framework, SWHR also encouraged ICER to explore how to quantify factors that matter to patients and society — such as ability to work, quality of life, level of disease burden, and caregiver burden — and incorporate these factors into value assessments. By developing standards for patient data collection and leveraging existing data sources, value frameworks will better reflect current reality and needs for diverse groups of patients. Doing this in an increasingly open and transparent manner and extending time for stakeholder review will further help to ensure models are accessible and tailored to patient populations.

Read SWHR’s Comments